Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
This is a phase 3 double-blind (DB), randomized, placebo-controlled study with an open-label long term extension (LTE) evaluating the efficacy and safety of Elafibranor 80 mg once daily versus placebo...
The purpose of this voluntary research study is to test the safety and ability to tolerate of the an injection treatment of the study drug AZD2693 in patients with Non-alcoholic...
This study is for patients with moderate to severely active ulcerative colitis to measure how effective and safe an experimental medication is in treating this condition....
This study is for patients with moderate to severely active Crohn's disease to measure how effective and safe an experimental medication is in treating this condition....
这一阶段3,双盲,随机,长期placebo-controlled, multicenter international study will evaluate the effect of OCA on histological improvements in NASH, all-cause mortality, and liver-related clinical outcomes. Primary Objective Assessed...
this study is looking for patients with compensated cirrhosis as the result of non-alcoholic steatohepatitis (NASH). ]). NASH is the result of too much fat within the liver, resulting in...
This study will compare the efficacy and safety of risankizumab versus ustekinumab for the treatment of adult subjects with moderate to severe Crohn's disease who have failed anti-TNF therapy....
This study is for patients with Celiac disease. We are studying whether an investigational drug will reduce symptoms associated with Celiac disease when taken while on a gluten free diet....
This study is for patients with Primary Sclerosing Cholangitis which is a chronic disease which causes scarring of the bile ducts. This can lead to damage of the liver over...
This study is for patients with Crohn's disease which involves an investigational new drug to treat perianal fistulas in patients with Crohn’s disease (CD). The purpose of this study is...
